...
search icon
hbio-img

Harvard Bioscience Inc, Common Stock

HBIO

NMQ

$1.98

+$0

(0%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$85.99M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.94K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.8 L
$4.93 H
$1.98

About Harvard Bioscience Inc, Common Stock

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameHBIOSectorS&P500
1-Week Return-9.59%1.76%-2.37%
1-Month Return-8.33%0.33%-3.79%
3-Month Return-20.48%-8.58%-0.46%
6-Month Return-40.36%-4.26%3.58%
1-Year Return-56.77%1.27%22.47%
3-Year Return-68.47%5.33%25.17%
5-Year Return-36.94%38.09%77.46%
10-Year Return-64.13%102.29%188.42%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue116.18M102.10M118.90M113.33M112.25M[{"date":"2019-12-31","value":97.71,"profit":true},{"date":"2020-12-31","value":85.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.32,"profit":true},{"date":"2023-12-31","value":94.4,"profit":true}]
Cost of Revenue51.85M44.06M51.25M52.52M46.18M[{"date":"2019-12-31","value":98.74,"profit":true},{"date":"2020-12-31","value":83.9,"profit":true},{"date":"2021-12-31","value":97.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.93,"profit":true}]
Gross Profit64.32M58.04M67.65M60.82M66.07M[{"date":"2019-12-31","value":95.08,"profit":true},{"date":"2020-12-31","value":85.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.9,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true}]
Gross Margin55.37%56.85%56.90%53.66%58.86%[{"date":"2019-12-31","value":94.06,"profit":true},{"date":"2020-12-31","value":96.58,"profit":true},{"date":"2021-12-31","value":96.66,"profit":true},{"date":"2022-12-31","value":91.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses62.48M57.82M65.59M67.98M64.18M[{"date":"2019-12-31","value":91.91,"profit":true},{"date":"2020-12-31","value":85.05,"profit":true},{"date":"2021-12-31","value":96.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.4,"profit":true}]
Operating Income1.47M(585.00K)1.40M(7.17M)1.89M[{"date":"2019-12-31","value":77.72,"profit":true},{"date":"2020-12-31","value":-30.89,"profit":false},{"date":"2021-12-31","value":73.92,"profit":true},{"date":"2022-12-31","value":-378.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(12.38M)(12.34M)(3.75M)(4.79M)(8.15M)[{"date":"2019-12-31","value":-1238400000,"profit":false},{"date":"2020-12-31","value":-1234400000,"profit":false},{"date":"2021-12-31","value":-374600000,"profit":false},{"date":"2022-12-31","value":-479400000,"profit":false},{"date":"2023-12-31","value":-814700000,"profit":false}]
Pre-Tax Income(5.50M)(7.29M)(140.00K)(9.18M)(2.56M)[{"date":"2019-12-31","value":-550200000,"profit":false},{"date":"2020-12-31","value":-729200000,"profit":false},{"date":"2021-12-31","value":-14000000,"profit":false},{"date":"2022-12-31","value":-917900000,"profit":false},{"date":"2023-12-31","value":-255600000,"profit":false}]
Income Taxes(815.00K)518.00K148.00K337.00K859.00K[{"date":"2019-12-31","value":-94.88,"profit":false},{"date":"2020-12-31","value":60.3,"profit":true},{"date":"2021-12-31","value":17.23,"profit":true},{"date":"2022-12-31","value":39.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(4.69M)(7.81M)(288.00K)(9.52M)(3.42M)[{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-341500000,"profit":false}]
Income From Continuous Operations(4.69M)(7.81M)(288.00K)(9.52M)(3.26M)[{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-326300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(4.69M)(7.81M)(288.00K)(9.52M)(3.42M)[{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-341500000,"profit":false}]
EPS (Diluted)0.180.160.250.120.15[{"date":"2019-12-31","value":72,"profit":true},{"date":"2020-12-31","value":64,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":48,"profit":true},{"date":"2023-12-31","value":60,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HBIO
Cash Ratio 0.20
Current Ratio 2.06
Quick Ratio 0.91

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HBIO
ROA (LTM) -1.98%
ROE (LTM) -20.40%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HBIO
Debt Ratio Lower is generally better. Negative is bad. 0.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.50

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HBIO
Trailing PE NM
Forward PE 14.93
P/S (TTM) 0.88
P/B 1.27
Price/FCF NM
EV/R 1.27
EV/Ebitda 179.26
PEG 2.89

FAQs

What is Harvard Bioscience Inc share price today?

Harvard Bioscience Inc (HBIO) share price today is $1.98

Can Indians buy Harvard Bioscience Inc shares?

Yes, Indians can buy shares of Harvard Bioscience Inc (HBIO) on Vested. To buy Harvard Bioscience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Harvard Bioscience Inc be purchased?

Yes, you can purchase fractional shares of Harvard Bioscience Inc (HBIO) via the Vested app. You can start investing in Harvard Bioscience Inc (HBIO) with a minimum investment of $1.

How to invest in Harvard Bioscience Inc shares from India?

You can invest in shares of Harvard Bioscience Inc (HBIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in HBIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Harvard Bioscience Inc shares
What is Harvard Bioscience Inc 52-week high and low stock price?

The 52-week high price of Harvard Bioscience Inc (HBIO) is $4.93. The 52-week low price of Harvard Bioscience Inc (HBIO) is $1.8.

What is Harvard Bioscience Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Harvard Bioscience Inc (HBIO) is

What is Harvard Bioscience Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Harvard Bioscience Inc (HBIO) is 1.27

What is Harvard Bioscience Inc dividend yield?

The dividend yield of Harvard Bioscience Inc (HBIO) is 0.00%

What is the Market Cap of Harvard Bioscience Inc?

The market capitalization of Harvard Bioscience Inc (HBIO) is $85.99M

What is Harvard Bioscience Inc’s stock symbol?

The stock symbol (or ticker) of Harvard Bioscience Inc is HBIO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top